Revolutionary Nasal Spray Could Delay Alzheimer’s Progression by Up to 15 Years

Nasal Spray May Delay Alzheimer’s Disease Progression

Alzheimer’s disease is a major cause of dementia, and its prevalence is expected to rise significantly. By 2050, an estimated 152.8 million people could have dementia, with about 70% suffering from Alzheimer’s. Current treatments mainly alleviate symptoms, and new disease-modifying therapies are limited.

Recent research from Texas A & M University College of Medicine introduced a nasal spray that shows promise in delaying Alzheimer’s symptoms. In a mouse model, this spray slowed brain inflammation and reduced harmful beta-amyloid protein buildup. The researchers suggest that if similar results are found in humans, the spray could delay the onset of Alzheimer’s by up to 15 years.

Microglia and astrocytes are cells in the brain involved in neuroinflammation. Initially, they protect nerve cells but become overactive in Alzheimer’s, leading to tissue damage. The study’s nasal spray targets these cells, aiming to reduce their inflammatory response.

In the study, researchers tested the nasal spray on mice genetically modified to exhibit Alzheimer’s symptoms. They administered two doses of the spray or a placebo. After treatment, the mice that received the spray showed fewer beta-amyloid plaques and less microglial activity compared to untreated mice.

Behavioral tests indicated that treated mice performed better in cognitive functions and mood assessments. This suggests potential benefits of the spray in improving brain health.

Experts emphasize that while these findings are promising, more research, including human studies, is needed to validate the results. Courtney Kloske from the Alzheimer’s Association highlights the importance of exploring various treatment methods, including nasal delivery systems.

Clifford Segil, a neurologist, points out that ongoing surveillance will be essential to determine the long-term effects and benefits of similar treatments in clinical settings.

Future research may enhance the diversity of Alzheimer’s therapies available. The goal is to develop a range of treatments targeting different aspects of the disease, potentially offering better outcomes for patients.